RxDoctor Payments DataLook up a doctor →

ELAPRASE: payments to doctors

Payments that named ELAPRASE as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$289K
Providers
882
Transactions
1,224
Average per transaction
$236

The per-transaction average — $236 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 882 providers the average total is $328, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Takeda Pharmaceuticals U.S.A., Inc.$223,27477.1%
Shire North American Group Inc$66,16922.9%
← All drugs & devices